Pharmacokinetics of sarafloxacin in allogynogenetic silver crucian carp, Carassius auratus gibelio

Abedini S, Namdari R, Law FCP (1998) Comparative pharmacokinetics and bioavailability of oxytetracycline in rainbow trout and chinook salmon. Aquaculture 162:23–32

Bowser PR, Wooster GA, Leger J, Babish JG (1992) Pharmacokinetics of enrofloxacin in fingerling rainbow trout (Oncorhynhus mykiss). J Vet Pharmacol Ther 15:62–71

Burka JF, Hammell KL, Horsberg TE, Johnson GR, Rainnie DJ, Speare DJ (1997) Drugs in salmonid aquaculture—a review. J Vet Pharmacol Ther 20:333–349

Chang CS (2009) Simultaneous determination of quinolones in marine and livestock products and pharmacokinetics of enrofloxacin in Tilapia. Ph.D. thesis, Department of Marine Biotechnology and Resources, National Sun Yat-sen University, Taiwan, pp 89–102 (in Chinese)

Chu WH, Lu CP (2000) Pathogenicity of Aeromonas hydrophila extracellular protease. J Nanjing Agric Univ 23:80–84 (in Chinese)

Drusano GL, Johnson DE, Rosen M, Standiford HC (1993) Pharmacodynamics of fluoroquinolone antimicrobial agent in neutropenic rat model of Pseudomonas sepsis. Antimicrob Agents Chemother 37:483–490

Duis K, Hammer C, Beveridge CM, Inglis V, Braum E (1995) Delivery of quinolone antibacterial to turbot, Scophthalmus maximus (L.) via bioencapsulation: quantification and efficacy trial. J Fish Dis 18:229–238

Fang X, Liu X, Liu W, Lu C (2012) Pharmacokinetics of enrofloxacin in allogynogenetic silver crucian carp, Carassius auratus gibelio. J Vet Pharmacol Ther 35:397–401

Haritova A, Lashev L, Pashov D (2003) Pharmacokinetics of enrofloxacin in lactating sheep. Res Vet Sci 74:241–245

Ho SP, Cheng CF, Wang WS (1999) Pharmacokinetic and depletion studies of sarafloxacin after oral administration to eel (Anguilla anguilla). J Vet Med Sci 61:459–463

Ingebrigtsen K (1991) Factors affecting drug disposition in fish. Acta Vet Scand (Suppl). 87:44–56

Intorre L, Cecchini S, Bertini S, Cognetti Varriale AM, Soldani G, Mengozzi G (2000) Pharmacokinetics of enrofloxacin in the seabass (Dicentrarchus labrax). Aquaculture 182:49–59

Johnson MR, Smith KL, Boyle CR (1992) Field efficacy trials of the antibacterial sarafloxacin -hydrochloride (A-56620) for treatment of Edwardsiella ictaluri infections in channel catfish. J Aquat Anim Health 4:244–251

Junger H, Kotrschal K, Goldschmid A (1989) Comparative morphology and ecomorphology of the gut in European cyprinids (Telostei). J Fish Bio 34:315–326

Koc F, Uney K, Atamanalp M, Tumer I, Kaban G (2009) Pharmacokinetic disposition of enrofloxacin in brown trout (Salmo trutta fario) after oral and intravenous administrations. Aquaculture 295:142–144

Lu CP (1992) Pathogenic Aeromonas hydrophila and the fish diseases caused by it. Journal of fisheries of china 16:282–287 (in Chinese)

Markwardt NM, Klontz GW (1989) A method to eliminate the asymptomatic carrier state of Aeromonas salmonicida in salmonids. J Fish Dis 12:317–322

Martinsen B, Horsberg TE (1995) Comparative single-dose pharmacokinetics of four quinolones, oxolinic acid, flumequine, sarafloxacin, and enrofloxacin, in Atlantic salmon (Salmo salar) held in seawater at 10°C. Antimicrob Agents Chemother 39:1059–1064

Martinsen B, Myhn E, Reed E, Hastein T (1991) In vitro antimicrobial activity of sarafloxacin against clinical isolates of bacteria pathogenic to fish. J Aquat Anim Health 3:235–241

Martinsen B, Horsberg TE, Sohlberg S, Burke M (1993a) Single-dose kinetic study of sarafloxacin after intravenous and oral administration of different formulations to Atlantic salmon (salmo salar) held in seawater at 8.5°C. Aquaculture 118:37–47

Martinsen B, Horsberg TE, Varma KJ, Sams RA (1993b) Single dose pharmacokinetic study of florfenicol in Atlantic salmon (Salmo salar) in seawater at 11°C. Aquaculture 112:1–11

Martinsen B, Horsberg TE, Ingebrigtsen K, Gross LE (1994a) Disposition of 14C-sarafloxacin in Atlantic salmon (Salmo salar), rainbow trout (Oncorhynchus mykiss), cod (Gadus morhua), and turbot (Scophtalmus maximus), as demonstrated by means of whole-body autoradiography and scintillation counting. Dis Aquat Org 18:37–44

Martinsen B, Horsberg TE, Burke M (1994b) Multiple-dose pharmacokinetic and depletion studies of sarafloxacin in Atlantic salmon, Salmo solar L. J Fish Dis 17:111–121

Park BK, Lim JH, Kim MS, Yun HI (2006) Pharmacokinetics of florfenicol and its metabolite, florfenicol amine, in the Korean catfish (Silurus asotus). J Vet Pharmacol Ther 29:37–40

Peng JH, Wang Y, Fang WH, Yao XJ, Fu GH (2013) Pharmacokinetics and pharmacodynamics of sarafloxacin hydrochloride in Eriocheir sinensis. Marine Fish 35:331–336 (In Chinese)

Smith DJ, Gingerich WH, Beconi-Barker MG (1999) Xenobiotics in Fish. Springer, New York, pp 123–130

Sun QH, Sun PF, Jin LH (1991) On the pathogenic bacteria of the hemolytic ascitesosis of allogynogenetic crucian carp. J Fish China 15:129–139 (in Chinese)

Wang ZQ, Zhu L (2005) Antibacterial activities of fluoroquinolones for animals against Aeromonas hydrophila and Aeromonas sobria. J Traditional Chinese Veterinary Medicine 2:34–36 (In Chinese)

Waterbeemd HVD, Lennernas H, Artursson P (2007) Drug bioavailability. Wiley, Weinheim, pp 430–440

Yamaoka K, Nakagawa T, Uno T (1978) Statistical moments in pharmacokinetics. J Pharmacokinet Biopharm 6:547–558

Zhanel GG (2001) Influence of pharmacokinetic and pharmacodynamic principles on antibiotic selection. Curr Infect Dis Rep 3:29–34